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Background
A large amount of literature surrounds the differences between
dissociative neurological symptom disorder with non-epileptic
seizures (DNSD-S) and epilepsy.
Aims
To explore the research gap on phenotypic differences between
DNSD-S and other psychiatric disorders.
Method
We conducted a case–control study of 1860 patients (620
patients with DNSD-S and 1240 controls with other psychiatric
disorders) seen at the South London and Maudsley Hospital NHS
Trust between 2007 and 2019.
Results
Compared with the controls, the patients with DNSD-S were
more likely to be female (76 v. 47%, P < 0.001), of White ethnicity
(77 v. 60%, P < 0.001), married (34 v. 14%, P < 0.001) and living in
areas of lower socioeconomic status (−3.79, 95% CI −2.62 to
−4.96, P < 0.001). Two peaks for age at diagnosis were observed
for DNSD-S: the early 20s and late 40s. After 31 years of age,
men’s chance of being diagnosed with DNSD-S increased from
19 to 28% (P = 0.009). People with DNSD-S presented more
commonly with a history of a neurological episodic or paroxys-
mal disorder (OR = 12, 95% CI 7.82–20.26), another dissociative
disorder (OR = 10, 95% CI 1.64– 65.95) or unclassified signs or
symptoms (OR = 4, 95% CI 2.61–6.43). Neither anxiety, depres-
sion nor other somatoform disorders predicted subsequent
diagnosis of DNSD-S, and controls had a larger proportion of
preceding psychiatric diagnoses than patients with DNSD-S (65 v.
49%, P < 0.001).
Conclusions
This is the first study comparing demographic and phenotypic
correlates of patients with DNSD-S against a large cohort of
psychiatric patients. These data will inform development and
drive service needs in psychiatry for people with DNSD-S.
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Dissociative neurological symptom disorder with non-epileptic sei-
zures (DNSD-S) is characterised by seizures or convulsions that are
not consistent with a recognised disease of the nervous system, other
mental or behavioural disorders or other health condition.
Classified within the functional neurological disorders in DSM-5
and dissociative neurological symptom disorder in ICD-11, they
are associated with a range of motor, sensory and mental manifesta-
tions and impaired self-control. Dissociative disorders have been
reported as highly prevalent in psychiatric out-patient samples,
and epidemiological studies have shown incidence rates for
DNSD-S ranging between 1.5 and 4.9 per 100 000 per year, with
prevalence rates ranging between 2 and 33 per 100 000.1,2 With
one in five referrals to a first seizure neurology clinic due to
DNSD-S,3 ultimately both neurologists and psychiatrists will find
themselves responsible for explaining the diagnosis to patients.
They will need to be equipped with knowledge to explain a referral
to psychiatry and how DNSD-S is different from other more well-
known conditions in psychiatry, while providing an explanation
of the mechanism behind how patients can develop physical symp-
toms through inorganic means. Clinicians will find it useful to give
further reasons using an evidenced-based archetypal presentation,
reassuring patients that they are not alone.
Despite increased interest into the aetiology of DNSD-S over the
past decade, the bulk of the literature thus far has only focused on
factors differentiating DNSD-S from epilepsy.4,5 This is valuable
at a diagnostic level, as people with DNSD-S are often misdiagnosed
with epilepsy and vice versa. However, DNSD-S is a psychiatric
condition and the mainstay of treatment is psychiatric and psycho-
logical.6 For all these reasons, it is astonishing the limited amount of
data about phenotypic differences between DNSD-S and other
mental disorders. These data are of great relevance for care provi-
sion, planning and outcome studies. In addition, the majority of
available studies are affected by a number of methodological limita-
tions, including small samples and retrospective design,6,7 with only
one study so far conducted at a population level.8 Goldstein and col-
leagues have taken the first step to characterising the typical presen-
tation of people with DNSD-S.8 However, more data are needed to
validate the preceding and predictive factors of DNSD-S in com-
parison with other psychiatric conditions. Findings suggest that
comorbid neurological diseases occur in 10% of people with func-
tional neurological disorders2 and comorbid epilepsy in 10–30%
of people with DNSD-S.9 Research suggests that affective disorders
can appear in 42%10 and functional somatic symptoms in 66–
70%11,12 of people with DNSD-S, with personality disorders also
being common.13 Data on medical and psychiatric history research
are available from several studies, yet all previous studies were con-
ducted with small samples, or lacked a psychiatric control group or
used people with epilepsy. In addition to this, most studies used a
top-down design to probe for diseases, with researchers using self-
report or relying on experience to ask for the presence of specific
conditions. It would be more robust to collect diagnostic data dir-
ectly from clinical notes. This is a case–control study investigating
the clinical characteristics of individuals with DNSD-S at diagnosis,
in a large cohort of people with other mental disorders.
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Method
Design, setting and data source
Medical records of patients seen at the South London andMaudsley
NHS Foundation Trust (SLaM) between 1 January 2007 and 6
November 2019 were analysed. SLaM is a National Health Service
mental health trust that provides mental healthcare to a population
of roughly 1.3 million residents in London, UK, as well as a national
referral service. In 2007, the National Institute for Health Research
(NIHR) Biomedical Research Centre at SLaM and King’s College
London developed the Clinical Record Interactive Search (CRIS)
system. CRIS provides researchers with regulated access to anon-
ymised information contained in SLaM’s medical records, including
over 250 000 patients.14,15
CRIS was approved as a secondary data resource by the National
Research Ethics Committee South Central Oxford C (ref: 18/SC/
0372). The CRIS Research Oversight Committee granted our
project access in March 2018 (project number 18-033).
Participant selection
Patients with DNSD-S were identified using CRIS by searching for
the ICD-10 code F44.5 (Dissociative seizures) as a diagnosis.
Patients for whom the code F44.5 was not the primary psychiatric
diagnosis were excluded because a secondary diagnosis is not con-
sidered the main condition in a phenotype, nor as driving the
major effect on the patient’s life. Furthermore, we wanted to focus
on DNSD-S as the primary problem from a psychopathological
point of view, rather than conditions where DNSD-S could be con-
sidered the consequence of other major psychiatric conditions, thus
masking the specific contribution of DNSD-S compared with a
general sample of patients with psychiatric disorders. Inclusion of
DNSD-S as a secondary diagnosis would have potentially biased
the sample, especially because it is compared with a general
sample of patients with psychiatric diagnoses. Cases and controls
with missing demographic data were excluded. All patients with
DNSD-S referred to SLaM already have a documented diagnosis
of DNSD-S according to International League Against Epilepsy
(ILAE) criteria11 made in an epilepsy centre.
For every DNSD-S ‘case’ we selected the two closest patients in
time who were diagnosed in SLaM with a different primary psychi-
atric diagnosis (F code in ICD-10) on the day the ‘case’ received
theirs. Controls were excluded if they had any history of ‘dissociative
seizures’ and each control could only be used as a match once.
Outcome variables
We gathered demographic data regarding participant’s gender, age,
ethnicity, marital status, socioeconomic score and age at diagnosis.
These variables were generally taken straight from CRIS. For tem-
poral variables such as marital status, the most recent information
at or before diagnosis was taken. For socioeconomic status, the
active address on the 6 November 2019 or themost recent preceding
address was used. Addresses were allocated to area scores according
to the English Index of Multiple Deprivation (2015)16, giving a score
of 1 (most deprived) to 32 844 (least deprived). Data on specific past
psychiatric conditions were pulled from the CRIS database because
we assumed that diagnoses delivered in a mental health service
would be more accurate than diagnoses made in primary care.
Data on past medical diagnoses were gathered by incorporating
data from the Hospital Episode Statistics (HES) database
(National Health Service, 2017). The HES database is linked with
the CRIS database via a third-party clinical linkage data service
using deterministic or probabilistic matching if/as required.15 This
database contains details of all diagnoses, admissions and out-
patient appointments at NHS hospitals across England. Owing to
the vast number of conditions within medicine, we initially
grouped medical diagnoses using the main chapters of ICD-10 to
highlight any significantly associated medical categories. Given
that past research has highlighted epilepsy in patients with dissocia-
tive seizures, we also broke down the G (neurology) ICD category to
assess the predictivity of all neurological conditions.
Statistical analysis
All variables were analysed using IMB SPSS Statistics software,
version 25 for Windows. Chi-square tests were used to compare
gender, ethnicity, marital status and all medical and psychiatric
history. T-tests were used to compare means of age at diagnosis
and deprivation score. Exploratory analyses included chi-square
comparisons within the DNSD-S group and between-group com-
parisons of age at diagnosis, split by the median. Binary logistic
regression was used to further assess all significant variables from
previous analyses to produce odds ratios.
Results
A total of 930 patients were identified to have a diagnosis of DNSD-S.
Of these, 104 had DNSD-S as a secondary diagnosis and were there-
fore removed, leaving 826 in the final DNSD-S group. Statistical com-
parisons between the secondary diagnosis group and the final
DNSD-S group showed no significant differences on all demographic
variables apart from gender, where those with primary DNSD-S
showed a greater proportion of females (76 v. 62%, χ2 = 8.207, d.f.
= 1, P = 0.004). Finally, cases or controls missing any demographic
data were removed to leave a clean data-set of 620 cases with 1240
matched controls. The primary diagnoses of the cohort are shown
in Table 1. Demographic frequencies, averages and between-group
comparisons statistics are displayed in Table 2.
On average, those in the DNSD-S group were younger than the
controls (33.4 v. 44.6 years). Age-at-diagnosis distributions are
shown in Figs 1 and 2. The DNSD-S group distribution shows
two peak ages at which patients generally received their diagnosis:
one in their early 20s and one in their early 40s. Exploring this
further, we split the DNSD-S group by median (31 years) and re-
ran chi-square comparisons. Ethnicity showed no group differences
above or below age 31 years. For gender, those in the DNSD-S group
were overall still more likely to be female, but the proportion of
males who received a diagnosis of DNSD-S significantly increased
after 31 years of age, from 19.4 to 28.3% (χ2 = 6.794, d.f. = 1, P =
0.009, φ = 0.009). We did not compare temporal variables because
these will be age dependent.
Historic mental and neurological conditions both showed sig-
nificant differences between our groups, which confirmed the deci-
sion to further break down these two categories from the CRIS and
HES databases. All prior diagnoses that reached significance were
input into a logistic analysis alongside demographic variables. The
results, including odds ratios, are displayed in Table 3. Individuals
with DNSD-S were identified by this model with a sensitivity of
84.4%, and controls were correctly discriminated with a specificity
of 92.6% (overall correct classification: 89.8%).
Discussion
This is the first study investigating demographic phenotypic differ-
ences between individuals with DNSD-S and those with other psy-
chiatric diagnoses. Those with DNSD-S were more likely to be
female (76 v. 47%), of White ethnicity (77 v. 60%), married or
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cohabitating (34 v. 14%) and to live in areas of lower socioeconomic
status (25.7 v. 29.5%).
Our study identified two peak ages at diagnosis. The first peak,
during the patients’ early 20s, has been previously documented by a
number of studies.1 The second peak, in their late 40s, is of particu-
lar interest. Differences between early- and late-onset DNSD-S have
been explored in a cohort of 241 patients, which showed that indi-
viduals with late-onset DNSD-S were more likely to be male and
have severe physical health problems.17 Our results confirm that,
although women are overall four times more likely to have
DNSD-S than men, significantly more men were diagnosed with
DNSD-S over the median age of 31 years (61%) compared with
women (49%). In this regard, it must be emphasised that our
study reported age at diagnosis rather than age at symptom onset
and for this reason the two peaks do not necessarily reflect a different
underlying aetiology or syndromic differences. However, Goldstein
and colleagues8 found a similar trend in terms of age at onset, support-
ing the intriguing possibility of genuine aetiological differences.
In terms of medical history and comorbidities, compared with
psychiatric controls, people with DNSD-S were 12 times more
likely to have a previous diagnosis of a paroxysmal neurological
condition such as epilepsy, and 10 times more likely to have had a
diagnosis of a dissociative disorder, including dissociative
amnesia, motor and anaesthesia symptoms. This may reflect a pre-
vious misdiagnosis of epilepsy4 but also the close relationship
between DNSD-S and other dissociative disorders.
The rate of concomitant psychiatric diagnoses is another
important finding of our study. Historically, people with DNSD-S
have been considered ‘complex’ because of the high rates of con-
comitant psychiatric problems.18 Our study found that one in two
in the DNSD-S group had a concomitant psychiatric problem but
this is not statistically different from our psychiatric control group,
pointing out that individuals with DNSD-S do not present a more
complex psychiatric comorbidity pattern compared with those with
other psychiatric disorders. More specifically, previous research has
shown anxiety disorders (such as post-traumatic stress disorder,
PTSD), depression and personality disorder to be common in
people with DNSD-S.10,13 Our results suggest that they are common
but they are not specific to patients with DNSD-S compared with
those with other psychiatric conditions, as a personality disorder pre-
dictor remained non-significant, and both anxiety disorder and
depression showed significant predictors, but odds ratios were
minimal (<1). Previous findings reflect the nature of the comparison,
which most of the time was with epilepsy.
Finally, our study contributes to the debate about the role of
somatisation and dissociation in people with DNSD-S. Previous
authors have pointed out this role.19 However, our study found a
low prevalence rate for somatisation the DNSD-S group that is
not statistically different from the rate in the psychiatric controls.
Although it may be the case that somatisation symptoms are
common,19 our results show, clinically, that they may be underdiag-
nosed and that dissociation symptoms, episodic paroxysmal disor-
ders, and symptoms, signs and abnormal clinical and laboratory
Table 1 Primary diagnoses for the cohort
Frequency, n %a
DNSD-S group
Dissociative seizures 620 100
Control group
Psychosis 381 30.7
Depressive/mood disorder 185 14.9
Mental and behavioural disorders due to










Personality disorders 65 5.2
Other organic mental disorder/condition
(e.g. delirium/unspecified)
32 2.6
Developmental disorders 17 1.4
Eating disorder 13 1.0
Delirium 7 0.6
Dissociative other/motor 6 0.5
Other somatoform disorders (neurasthenia
or depersonalisation)
6 0.5
Unspecified mental disorder with
physiological dysfunction
<5b <4b
DNSD-S, dissociative neurological symptom disorder with non-epileptic seizures; OCD,
obsessive–compulsive disorder; PTSD, post-traumatic stress disorder.
a. Percentages (%) are of the total cohort or control group.
b. To maintain confidentiality, frequency values considered ‘small’ (n < 5) were not
shown individually.
Table 2 Demographic frequencies, averages and comparison statistics of the DNSD-S group and controls
DNSD-S group, n = 620 Controls, n = 1240 Test, significance (P), effect size
(φ, Cramer’s V or Cohen’s d)Frequency, n % Frequency, n %
Male* 149 24.0 657 53.0 χ2 = 141.09, d.f. = 1, P < 0.001, φ = 0.275
Female* 471 76.0 583 47.0
White* 479 77.3 746 60.2 χ2 = 139.88, d.f. = 5, P < 0.001, V = 0.274
Black* 59 9.5 344 27.7
Mixed 13 2.1 39 3.1
Other ethnic group 26 4.2 43 3.5
Asian* 18 2.9 68 5.5 χ2 = 139.88, d.f. = 5, P < 0.001, V = 0.274
Chose not to disclose* 25 4.0 0 0.0
Single* 348 56.1 836 67.4 χ2 = 128.87, d.f. = 5, P < 0.001, V = 0.263
Married/cohabitating* 213 34.4 173 14.0
Divorced* 26 4.2 104 8.4
Widowed* 6 1.0 47 3.8
Separated* 12 1.9 66 5.3
Chose not to disclose* 15 2.4 14 1.1
Mean s.d. Mean s.d.
Age at diagnosis, years* 33.4 13.8 44.6 17.5 t = 13.93, d.f. = 1858, P < 0.001, d = 0.71 (m.d. = 11.19,
95% CI 9.62–12.77)
Socioeconomic status* (IMD score) 25.7 14.1 29.5 11.1 t = 6.34, d.f. = 1858, P < 0.001, d = 0.29 (m.d. = 3.79,
95% CI 2.62–4.96)
DNSD-S, dissociative neurological symptom disorder with non-epileptic seizures; m.d., mean difference; IMD, index of multiple deprivation.
* Indicates a significant difference (P < 0.05).
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findings ‘not elsewhere classified’ may be just as, if not, more
important. However, we should add the caveat that our sample
potentially missed patients who had received an ICD diagnosis
code of ‘mixed dissociative disorder’ that included dissociative sei-
zures and who could have potentially showed greater somatisation.
Regardless, this is an interesting finding, given the high associations
between dissociative mechanisms and adverse events and trauma –
both prevalent in the DNSD-S population.20
Limitations
We should bear in mind that our findings will be somewhat influ-
enced by the data’s source; for example, hospital primary care
data will not capture lesser medical conditions that do not require
hospital attendance. Ideally, we would have analysed the incidence
of medical conditions rather than dichotomously recording whether
a condition had occurred in the past. However, we did not want to






























Age at diagnosis, years
60 80 100
Fig. 2 Age at diagnosis of psychiatric disorders in the control group.
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groups. Plus, this approach would have been more susceptible to
reporter bias. Ideally, structured interviews would have been
administered to glean these data, minimising reporter bias and
allowing accurate diagnosis-frequency calculations. This is espe-
cially important in this area, given that there are generally issues
with the reporting of complex disorders such as somatisation in
routine clinical practice in general. However, owing to the retro-
spective nature and large numbers, this was not possible for the
current study. The data were cross-sectional, and we therefore
had to interpret temporal variables such as marital status with
caution as they might change. We were unable to record the age
at onset of a condition, only the age at which a patient was diag-
nosed. Next, although in our sample electroencephalogram (EEG)
was the gold standard for diagnosis of DNSD-S, we did not check
individual EEG results. Some individuals may have diagnoses
based on experts’ clinical judgement, which, naturally, increases
risk of misdiagnoses. We should also bear in mind that patients
with DNSD-S classified as a secondary diagnosis were removed
from our sample. As a consequence, our results may not be valid
in this population of patients. However, the numbers was small,
and the purpose of this study was to focus on patients with
DNSD-S as a primary diagnosis. Finally, we should reiterate that
we used the ICD codes to group individuals with DNSD-S, which
means that we will have missed patients with DNSD-S who also
had other dissociative symptoms and were given the diagnosis
‘F44.7 Mixed dissociative [conversion] disorders’.
Implications
Our findings aid other studies in clarifying the clinical and demo-
graphic characteristics of the DNSD-S patient population relative
to the population with other psychiatric conditions. Clinicians
should be aware of the increased incidence of DNSD-S diagnoses
around the age of 40, rather than simply in the early 20s. The pres-
ence of prior paroxysmal symptoms, both neurological and dis-
sociative, are more valid characteristics of DNSD-S than mood
Table 3 Logistic regression results for relative predictors of a diagnosis of DNSD-Sa
B s.e. Wald d.f. P ORb,c,d
95% CI for Exp(B)
Lower Upper
Age at diagnosis, years* −0.056 0.007 61.918 1 0.000 0.945 0.932 0.959
IMD score* −0.015 0.007 5.368 1 0.021 0.985 0.972 0.998
Female* 1.082 0.188 32.957 1 0.000 2.951 2.039 4.269
Ethnicity 7.116 5 0.212
White −0.343 0.247 1.938 1 0.164 0.709 0.437 1.150
Black −0.189 0.463 0.167 1 0.683 0.828 0.334 2.051
Mixed 0.174 0.414 0.176 1 0.675 1.190 0.528 2.680
Other* −1.013 0.439 5.331 1 0.021 0.363 0.154 0.858
Asian 20.399 7060.346 0.000 1 0.998 722 942 556.108 0.000
Marital status* 42.050 5 0.000
Single* 1.374 0.231 35.413 1 0.000 3.953 2.514 6.215
Married/cohabitating −0.060 0.382 0.025 1 0.874 0.941 0.445 1.991
Divorced −0.121 0.544 0.049 1 0.824 0.886 0.305 2.574
Separated 0.013 0.764 0.000 1 0.987 1.013 0.227 4.529
Widowed −0.352 0.586 0.360 1 0.548 0.703 0.223 2.218
Diseases of the eye and adnexa 0.637 0.338 3.553 1 0.059 1.892 0.975 3.670
Diseases of the ear and mastoid process 0.893 0.579 2.382 1 0.123 2.443 0.786 7.592
Respiratory disease −0.068 0.229 0.087 1 0.768 0.934 0.596 1.465
Diseases of the digestive system −0.068 0.214 0.101 1 0.751 0.934 0.614 1.421
Diseases of the musculoskeletal system and connective tissue 0.087 0.240 0.132 1 0.716 1.091 0.682 1.745
Diseases of the genitourinary system 0.080 0.228 0.122 1 0.727 1.083 0.692 1.694
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified* 1.410 0.230 37.500 1 0.000 4.095 2.608 6.430
Factors influencing health status and contact with health services −0.294 0.216 1.843 1 0.175 0.745 0.488 1.139
Other degenerative diseases of the nervous system −0.948 1.012 0.878 1 0.349 0.388 0.053 2.814
Episodic and paroxysmal disorders* 2.533 0.243 108.916 1 0.000 12.590 7.824 20.260
Nerve, nerve root and plexus disorders 0.743 0.506 2.157 1 0.142 2.102 0.780 5.668
Diseases of myoneural junction and muscle 0.118 1.235 0.009 1 0.924 1.125 0.100 12.665
Cerebral palsy and other paralytic syndromes −0.121 0.591 0.042 1 0.838 0.886 0.278 2.824
Other disorders of the nervous system 0.157 0.438 0.129 1 0.719 1.170 0.496 2.760
Dementia −20.169 4861.184 0.000 1 0.997 0.000 0.000
Mental and behavioural disorders due to use of alcohol and drugs* −3.080 0.467 43.530 1 0.000 0.046 0.018 0.115
Psychosis* −3.477 0.479 52.683 1 0.000 0.031 0.012 0.079
Mania/bipolar disorder −20.633 2745.750 0.000 1 0.994 0.000 0.000
Depressive/mood disorder* −2.323 0.302 59.332 1 0.000 0.098 0.054 0.177
Anxiety disorder (phobic/general/OCD/PTSD) * −1.499 0.317 22.418 1 0.000 0.223 0.120 0.415
Dissociative other/motor* 2.342 0.942 6.182 1 0.013 10.407 1.642 65.952
Personality disorders −0.337 0.490 0.473 1 0.492 0.714 0.273 1.865
Mental retardation* −2.101 0.924 5.174 1 0.023 0.122 0.020 0.748
Developmental disorders −0.834 0.564 2.188 1 0.139 0.434 0.144 1.311
Hyperkinetic/conduct/unspecified child-onset disorder* −1.503 0.516 8.491 1 0.004 0.223 0.081 0.611
Unspecified* −0.572 0.275 4.335 1 0.037 0.565 0.330 0.967
Constant 0.864 0.329 6.904 1 0.009 2.373
DNSD-S, dissociative neurological symptom disorder with non-epileptic seizures; IMD, index of multiple deprivation; OCD, obsessive–compulsive disorder; PTSD, post-traumatic stress
disorder.
a. Diagnostic categories for mental and neurological conditions are from ICD-10.
b. Odds ratios indicate the predictiveness of developing DNSD-S given the presence of a variable characteristic.
c. χ2 = 1460.728, d.f. = 39, P < 0.001 – model coefficients.
d. χ2 = 9.030, d.f. = 8, P = 0.340 – Hosmer–Lemeshow goodness-of-fit test.
* Indicates a significant contribution to the model.
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and anxiety conditions. Other pathological conditions may be
important when identifying DNSD-S in neurological clinics, but
this may not be so important when it comes to pathological aeti-
ology and psychological treatment. Perhaps we place too great an
emphasis and assume high psychiatric comorbidity in patients
with DNSD-S because of past comparison with patients with epi-
lepsy. The high predictivity of other neurological, functional and
dissociative symptoms could suggest a common behavioural aeti-
ology in these patients. It would be helpful for future studies to
compare the behaviours and cognitions among DNSD-S patients
to establish phenotypes. Any differences would be important to
inform therapists of potential areas to target during treatment.
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